Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging

NCT04752137 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04752137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04752137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
May 25, 2022
Completion date
April 1, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign neoplasm, malignant neoplasm